ArticleJMIR research protocols2026
REVISE Virtual Reality Intervention to Prevent Sexual Harassment in Heterosexual Couples: Protocol for a Randomized Controlled Trial.
Article in JMIR research protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06839937 (A Virtual Reality Couples' Intervention for Sexual Victimization Prevention), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Virtual Reality Couples' Intervention for Sexual Victimization Prevention: a Gender-swapping Transformative Approach (REVISE)
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA series of studies suggests that immersive virtual reality (IVR) can enhance perspective-taking and behavioral change by simulating real-world scenarios experienced from different points of view. IVR has emerged as a promising tool for the prevention of gender-based violence, including sexual harassment. However, evidence on the effectiveness of first-person embodiment-based interventions in fostering empathy and modifying gender-related attitudes remains limited.
objectiveThis study aims to evaluate the efficacy of REVISE (Realidad Virtual Inmersiva y Sexualidad), an IVR-based intervention designed to influence beliefs related to sexual aggression and related psychosocial mechanisms in heterosexual men through partner identity exchange.
methodsNinety heterosexual couples will be randomly assigned to one of three experimental conditions: (1) IVR with partner identity exchange in a sexual harassment scenario, (2) IVR with partner identity exchange in a neutral scenario, or (3) third-person observation of a sexual harassment scenario. The intervention consists of a single IVR session, with assessments conducted at baseline, postintervention, and at 3-month follow-up. Data will include self-report questionnaires, physiological measures (eye tracking and pupillometry), and semistructured qualitative interviews. The primary outcome is the change in beliefs related to sexual aggression. Secondary outcomes include empathy, gender role attitudes, relationship functioning, and physiological responses.
resultsAt the time of manuscript submission, recruitment had not yet begun. The study is expected to generate quantitative and qualitative data on changes in beliefs related to sexual aggression, empathy, gender-related attitudes, and physiological responses across experimental conditions.
conclusionsThe REVISE trial will contribute to the evidence base on IVR interventions for the prevention of gender-based violence. By integrating embodiment, behavioral simulation, and multimodal assessment, this study may inform the development of future technology-based interventions aimed at promoting gender-equitable and prosocial behaviors.
trial registrationClinicalTrials.gov NCT06839937; https://clinicaltrials.gov/study/NCT06839937. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/91993.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.